CASI Pharmaceuticals
CASI
#10629
Rank
S$5.44 M
Marketcap
S$0.27
Share price
0.00%
Change (1 day)
-88.89%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -S$62.15 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$26.84 Million. In 2024 the company made an earning of -S$48.64 Million a decrease over its 2023 earnings that were of -S$33.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$62.15 Million27.78%
2024 -S$48.64 Million44.35%
2023 -S$33.7 Million-29.55%
2022 -S$47.83 Million4.43%
2021 -S$45.8 Million-24.56%
2020 -S$60.71 Million4.74%
2019 -S$57.96 Million65.13%
2018 -S$35.1 Million155.07%
2017 -S$13.77 Million13.93%
2016 -S$12.08 Million31.18%
2015 -S$9.21 Million-72.5%
2014 -S$33.48 Million356.62%
2013 -S$7.34 Million-60.55%
2012 -S$18.59 Million218.41%
2011 -S$5.84 Million0.74%
2010 -S$5.8 Million-32.54%
2009 -S$8.59 Million-66.98%
2008 -S$26.01 Million-14.22%
2007 -S$30.32 Million7.04%
2006 -S$28.33 Million27.95%
2005 -S$22.14 Million4.51%
2004 -S$21.19 Million-15.84%
2003 -S$25.17 Million-55.29%
2002 -S$56.3 Million-34.05%
2001 -S$85.37 Million31.73%
2000 -S$64.8 Million31.56%
1999 -S$49.26 Million145.56%
1998 -S$20.06 Million76.4%
1997 -S$11.38 Million36.92%
1996 -S$8.31 Million